Alprazolam, caffeine and their interaction: relating DRL performance to pharmacokinetics

Area of Science:

• Pharmacology
• Behavioral Neuroscience
• Drug Interactions

Background:

• Differential reinforcement of low-rate behavior (DRL) is a key operant behavior sensitive to drug effects.
• Alprazolam and caffeine are commonly used psychoactive substances with distinct pharmacokinetic profiles.
• Understanding drug interactions is crucial for predicting combined effects on behavior.

Purpose of the Study:

• To investigate the behavioral interactions between alprazolam and caffeine in rats using the DRL 45-s schedule.
• To characterize the nature of these interactions (additive, independent, synergistic, or antagonistic) over time.
• To examine the influence of drug concentrations on behavioral effects and pharmacokinetic profiles.

Main Methods:

• Rats were trained on a DRL 45-s schedule to assess drug effects.
• Dose-response curves (DRCs) and behavior-time profiles were used to analyze drug interactions.
• Serum concentrations of alprazolam and caffeine were measured and correlated with behavioral outcomes.
• Pöch's DRC method was employed to evaluate interaction types.

Main Results:

• Alprazolam was more potent than caffeine in disrupting DRL behavior.
• Combined effects were not distinguishable as additive or independent, showing neither synergism nor antagonism.
• Alprazolam's shorter half-life (32 min) compared to caffeine (3 h) led to changing potency ratios over the session.
• Caffeine did not alter alprazolam pharmacokinetics, but alprazolam affected caffeine pharmacokinetics.

Conclusions:

• The interaction between alprazolam and caffeine on DRL behavior is complex and time-dependent.
• Neither synergistic nor antagonistic interactions were observed, suggesting a more nuanced relationship.
• Pharmacokinetic alterations, particularly of caffeine by alprazolam, play a role in the observed behavioral effects.